Christopher Abbott
Geen lopende functies
Vermogen: 17 M $ op 31-03-2024
Profiel
Christopher M.
Abbott was the Chairman-Emeritus and founder of Genetic Signatures Ltd.
Dr. Abbott is also the founder of Peplin Ltd., Maple-Brown Abbott Ltd.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GENETIC SIGNATURES LTD.
20.59% | 28-08-2023 | 38 392 200 ( 20.59% ) | 17 M $ | 31-03-2024 |
Eerdere bekende functies van Christopher Abbott
| Bedrijven | Functie | Einde |
|---|---|---|
Maple-Brown Abbott Ltd.
 Maple-Brown Abbott Ltd. Investment ManagersFinance Maple-Brown Abbott Ltd. (MBA) is an investment management firm headquartered in Sydney, Australia. The firm was founded by Robert Maple-Brown and Chris Abbott in 1984. They are a subsidiary of Maple-Brown Family Investments Pty Ltd. The firm offers Australian managed investment schemes, UCITS (Undertaking for Collective Investment in Transferable Securities) funds in a variety of currencies and discrete mandates to clients around the world. Their clients include superannuation funds, financial institutions, endowments, charities, family offices, financial advisers, wholesale investors and retail investors. MBA is a socially responsible investor and a signatory to the UN Principles for Responsible Investment (UNPRI). | Founder | - |
Peplin Ltd.
 Peplin Ltd. Pharmaceuticals: OtherHealth Technology Peplin Ltd. provides development and commercialisation of prescription human therapeutic products for the treatment of cancer. It also provides drug development process, clinical development and pre-clinical development services. It was was founded in 1998 and is located in Newstead, Australia | Founder | - |
| GENETIC SIGNATURES LIMITED | Founder | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GENETIC SIGNATURES LIMITED | Commercial Services |
| Bedrijven in privébezit | 2 |
|---|---|
Peplin Ltd.
Peplin Ltd. Pharmaceuticals: OtherHealth Technology Peplin Ltd. provides development and commercialisation of prescription human therapeutic products for the treatment of cancer. It also provides drug development process, clinical development and pre-clinical development services. It was was founded in 1998 and is located in Newstead, Australia | Health Technology |
Maple-Brown Abbott Ltd.
Maple-Brown Abbott Ltd. Investment ManagersFinance Maple-Brown Abbott Ltd. (MBA) is an investment management firm headquartered in Sydney, Australia. The firm was founded by Robert Maple-Brown and Chris Abbott in 1984. They are a subsidiary of Maple-Brown Family Investments Pty Ltd. The firm offers Australian managed investment schemes, UCITS (Undertaking for Collective Investment in Transferable Securities) funds in a variety of currencies and discrete mandates to clients around the world. Their clients include superannuation funds, financial institutions, endowments, charities, family offices, financial advisers, wholesale investors and retail investors. MBA is a socially responsible investor and a signatory to the UN Principles for Responsible Investment (UNPRI). | Finance |
